Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Naehrlich

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Deutsches Arzteblatt International|January 22, 2025
The Prevalence of Cystic Fibrosis—a Comparison of Patient Registry Data and Billing Data Within the German Statutory Health Insurance SystemLutz Naehrlich, Christian Gallowitz, Manuel Burkhart, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 12, 2013
Individualized vitamin A supplementation for patients with cystic fibrosisChristina Brei, Annette Simon, Michael B Krawinkel, et al.
Scientific Reports|November 5, 2020
Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung functionUta Düesberg, Julia Wosniok, Lutz Naehrlich, et al.
BMC Pulmonary Medicine|October 5, 2014
Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control studyAzadeh Bagheri-Hanson, Sebastian Nedwed, Claudia Rueckes-Nilges, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|October 31, 2012
Iodine deficiency and subclinical hypothyroidism are common in cystic fibrosis patientsLutz Naehrlich, Helmuth-Günther Dörr, Azadeh Bagheri-Behrouzi, et al.
ERJ Open Research|May 13, 2026
Off-label treatment with elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: real-world evidence from the German CF RegistryMirjam Stahl, Florian S Gerts, Sylvia Hafkemeyer, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 15, 2007
Functional characterization of a novel CFTR mutation P67S identified in a patient with atypical cystic fibrosisCornelia Kraus, André Reis, Lutz Naehrlich, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 24, 2024
Effectiveness of lumacaftor/ivacaftor initiation in children with cystic fibrosis aged 2 through 5 years on disease progression: Interim results from an ongoing registry-based studyClaire Kim, Mark Higgins, Lingyun Liu, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 7, 2025
Heterogeneous use of multiple breath washout in cystic fibrosis across age groups and European countries: an ECFSPR analysisAnna Zolin, Simone Gambazza, Anders Lindblad, et al.
Respiratory Medicine|October 31, 2025
Changes in use of inhaled chronic antibiotics in the European CF population: an ECFS patient registry studyMarianne S Muhlebach, Lutz Naehrlich, Siobhán B Carr, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Deutsches Arzteblatt International|January 22, 2025
The Prevalence of Cystic Fibrosis—a Comparison of Patient Registry Data and Billing Data Within the German Statutory Health Insurance SystemLutz Naehrlich, Christian Gallowitz, Manuel Burkhart, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 12, 2013
Individualized vitamin A supplementation for patients with cystic fibrosisChristina Brei, Annette Simon, Michael B Krawinkel, et al.
Scientific Reports|November 5, 2020
Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung functionUta Düesberg, Julia Wosniok, Lutz Naehrlich, et al.
BMC Pulmonary Medicine|October 5, 2014
Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control studyAzadeh Bagheri-Hanson, Sebastian Nedwed, Claudia Rueckes-Nilges, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|October 31, 2012
Iodine deficiency and subclinical hypothyroidism are common in cystic fibrosis patientsLutz Naehrlich, Helmuth-Günther Dörr, Azadeh Bagheri-Behrouzi, et al.
ERJ Open Research|May 13, 2026
Off-label treatment with elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: real-world evidence from the German CF RegistryMirjam Stahl, Florian S Gerts, Sylvia Hafkemeyer, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 15, 2007
Functional characterization of a novel CFTR mutation P67S identified in a patient with atypical cystic fibrosisCornelia Kraus, André Reis, Lutz Naehrlich, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 24, 2024
Effectiveness of lumacaftor/ivacaftor initiation in children with cystic fibrosis aged 2 through 5 years on disease progression: Interim results from an ongoing registry-based studyClaire Kim, Mark Higgins, Lingyun Liu, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 7, 2025
Heterogeneous use of multiple breath washout in cystic fibrosis across age groups and European countries: an ECFSPR analysisAnna Zolin, Simone Gambazza, Anders Lindblad, et al.
Respiratory Medicine|October 31, 2025
Changes in use of inhaled chronic antibiotics in the European CF population: an ECFS patient registry studyMarianne S Muhlebach, Lutz Naehrlich, Siobhán B Carr, et al.
Pageof 9